PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2022.3592023552488-497Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation SequencingBeung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Limhttp://e-crt.org/upload/pdf/crt-2022-359.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2022.359, http://e-crt.org/upload/pdf/crt-2022-359.pdf
10.21203/rs.3.rs-1246803/v12022Association of Next Generation Sequencing and Routine Testing With Clinical Outcomes of Advanced Non-small Cell Lung Cancer Patients in a Real-world SettingZhengbo Song, Wenxian Wang, Jinfei Si, Xiaoyan Zhang, Tonghui Ma, Guangyuan Lou, Zhiyong Shi, Lan Shao, Yiping Zhanghttps://www.researchsquare.com/article/rs-1246803/v1, https://www.researchsquare.com/article/rs-1246803/v1.html
Annals of Oncology10.1016/j.annonc.2020.08.1683202031S8741369P EGFR T790M ctDNA abundance and TP53 co-mutation by next generation sequencing predicted clinical outcomes of osimertinib in non-small cell lung cancer patients from a real-world studyT. Tian, X. Fu, W. Wang, L. Jiang, X. Liang, Z. Ruan, Y. Yaohttps://api.elsevier.com/content/article/PII:S0923753420416795?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420416795?httpAccept=text/plain
Journal of Thoracic Oncology10.1016/j.jtho.2021.08.53720211610S1117-S1118P50.09 Characteristics and Clinical Outcomes of HER2 Mutated Non-small Cell Lung Cancer Patients Detected by NGS in Routine Clinical PracticeY. Han, S.M. Lim, H.R. Kim, M.H. Hong, B.C. Cho, B. Ahnhttps://api.elsevier.com/content/article/PII:S1556086421029609?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086421029609?httpAccept=text/plain
10.21203/rs.3.rs-273496/v12021Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancersPeiyi Xia, Lan Zhang, Pan Li, Enjie Liu, Wencai Li, Jianying Zhang, Hui Li, Xiaoxing Su, Guozhong Jianghttps://www.researchsquare.com/article/rs-273496/v1, https://www.researchsquare.com/article/rs-273496/v1.html
Annals of Oncology10.1093/annonc/mdz437.043201930ix174Real world prospective clinical impact of finding actionable genomic alterations by plasma cell-free DNA next generation sequencing in advanced non-small cell lung cancerB.C. Ahn, S. Lee, Y.J. Chun, M.H. Hong, H.R. Kim, B.C. Chohttps://api.elsevier.com/content/article/PII:S0923753419581637?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419581637?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/30/Supplement_9/mdz437.043/31094567/mdz437.043.pdf, http://academic.oup.com/annonc/article-pdf/30/Supplement_9/mdz437.043/31094567/mdz437.043.pdf
Current Oncology10.3390/curroncol3008051520233087099-7111Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung CancerKelly Li, Ian Bosdet, Stephen Yip, Cheryl Ho, Janessa Laskin, Barbara Melosky, Ying Wang, Sophie Sunhttps://www.mdpi.com/1718-7729/30/8/515/pdf
Cancers10.3390/cancers1309204920211392049Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma PatientsPaul Hofmanhttps://www.mdpi.com/2072-6694/13/9/2049/pdf
ESMO Open10.1136/esmoopen-2020-001011202056e001011Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patientsAdam Pluzanski, Maciej Krzakowski, Dariusz Kowalski, Rafal Dziadziuszkohttps://api.elsevier.com/content/article/PII:S2059702920327551?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2059702920327551?httpAccept=text/plain, https://syndication.highwire.org/content/doi/10.1136/esmoopen-2020-001011
Drugs - Real World Outcomes10.1007/s40801-020-00207-6202074261-269Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung CancerDavid M. Waterhouse, Janet L. Espirito, Marc D. Chioda, Bismark Baidoo, Jack Mardekian, Nicholas J. Robert, Elizabeth T. Mastershttps://link.springer.com/content/pdf/10.1007/s40801-020-00207-6.pdf, https://link.springer.com/article/10.1007/s40801-020-00207-6/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40801-020-00207-6.pdf